Cutting-Edge Science and Technology to Deliver New Therapeutic Applications
The Emerging Therapeutics & Technologies stream presents three emerging and fast-developing topics, that represent the latest trends and future outlook for many biologics developers. Emerging Indications for Therapeutic Antibodies will reveal new targets and novel mechanisms of actions for development of next-generation therapeutics beyond oncology. Gene Therapy: Advancing from Bench to Clinic will explore the exciting landscape of gene therapy, highlighting
regulatory, commercialization and analytical strategies, and showcasing case studies of gene therapies in rare and neurological diseases.
August 31 - September 1
Emerging Indications for Therapeutic Antibodies
Keynote Speakers Include:
Madhusudan Natarajan, PhD, Head, Rare Diseases DDU, Takeda
Mike Singer, PhD, Medical Officer, Division of Clinical Evaluation and Pharmacology/Toxicology, Center for Biologics Evaluation and Research, FDA